Scharioth Macula Lens: A new intraocular implant for low-vision patients with stabilized maculopathy- first experience

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F17%3A73585384" target="_blank" >RIV/61989592:15110/17:73585384 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11150/17:10366639 RIV/00179906:_____/17:10366639
Result on the web
<a href="http://biomed.papers.upol.cz/pdfs/bio/2017/02/12.pdf" target="_blank" >http://biomed.papers.upol.cz/pdfs/bio/2017/02/12.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5507/bp.2017.014" target="_blank" >10.5507/bp.2017.014</a>

Result language
angličtina
Original language name
Scharioth Macula Lens: A new intraocular implant for low-vision patients with stabilized maculopathy- first experience
Original language description
AIMS: To present the initial results of Scharioth Macula Lens (SML) implantation. The SML is a new add-on intraocular lens designed to increase uncorrected near visual acuity (UCVA) in patients with stabilized maculopathy. METHODS: Eight patients were included in the study. All met the indication criteria before SML implantation. An SML was implanted in the better seeing eye. Near and distance visual acuity were tested. Possible complications and patient complaints were recorded and patients were asked about their quality of vision after SML implantation. The examination was carried out on day 1, 1 week, 1, 3 and 6 months after surgery.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30502 - Other medical science

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)